NCI-2022-08263

Phase III Prospective Randomized Trial of Primary Lung Tumor Stereotactic Body Radiation Therapy Followed by Concurrent Mediastinal Chemoradiation for Locally-Advanced Non-Small Cell Lung Cancer

This research study investigates whether combining SBRT for the primary lung tumor with concurrent mediastinal chemoradiation improves outcomes for patients with locally-advanced NSCLC compared to standard treatments. This refers to lung cancers that are more advanced than early-stage (stage I or II) but have not spread extensively to distant parts of the body (stage III). SBRT is a technique where very precise, high-dose radiation is delivered to the tumor, typically in a few (often 1-5) sessions. It's used for localized tumors and aims to deliver radiation with minimal damage to surrounding healthy tissue.

For more information about the trial, click the link below:

https://clinicaltrials.gov/ct2/show/NCT05624996v

Clinical Trial Site: Einstein

To see all available clinical trials click here.